Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.
The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. It is currently operating in Stealth mode.
Andrew Kruegel established the biotech company in 2017 in Dobbs Ferry, New York.
Upgrade this company profile// Update & customize all content. Ask PharmaCompass, click HERE.
Greater New York Area, East Coast, Northeastern US